期刊文献+

传统格栅样激光与577nm黄色微脉冲激光光凝治疗黄斑水肿疗效对比 被引量:12

Comparison of traditional grid laser and 577nm yellow micropulse laser photocoagulation for macular edema
下载PDF
导出
摘要 目的比较传统格栅样激光光凝(macular laser grid photocoagulation,MLG)与577 nm黄色微脉冲激光治疗黄斑水肿(macular edema,ME)的临床疗效。方法经眼底检查及光学相干断层扫描(optical coherence tomography,OCT)检查确诊的ME患者97例116眼纳入研究。将患者采用随机数字表法分为MLG组和微脉冲组,分别为46例57眼、51例59眼。MLG组行561nm黄绿光连续波长激光光凝治疗,微脉冲组患者行577 nm黄色微脉冲激光治疗。治疗前后所有患者均行眼底、矫正视力、OCT及微视野检查,检测其矫正视力、黄斑中心视网膜厚度(central macular thickness,CMT)及黄斑10°范围内视网膜光敏感度。以治疗后6个月为疗效判定时间点,观察患者治疗前后矫正视力、CMT及光敏感度的变化,对比分析治疗前后两组患者矫正视力、CMT及光敏感度差值之间的差异。结果治疗后6个月,MLG组、微脉冲组矫正视力分别为0.41±0.20、0.44±0.18,均较治疗前提高,差异均有统计学意义(t=2.703、3.398,均为P<0.05)。两组治疗前后矫正视力的差值分别为0.07±0.03、0.09±0.02,两组间差值比较差异无统计学意义(t=0.584,P>0.05)。治疗后MLG组、微脉冲组CMT分别为(328.13±107.66)μm、(316.54±73.21)μm,均较治疗前降低,差异均有统计学意义(t=2.028、4.086,均为P<0.05)。两组治疗前后CMT的差值分别为(24.71±11.09)μm、(53.27±13.67)μm,两组差值比较差异无统计学意义(t=1.891,P>0.05)。治疗后MLG组、微脉冲组光敏感度分别为(4.33±1.72)dB、(6.52±2.56)dB;MLG组光敏感度较治疗前降低,差异有统计学意义(t=3.381,P<0.05);微脉冲组光敏感度较治疗前提高,差异也有统计学意义(t=3.569,P<0.05)。MLG组、微脉冲组治疗前后光敏感度差值分别为(-0.89±0.26)dB、(1.12±0.31)dB,两组差值比较差异有统计学意义(t=4.791,P<0.05)。结论 577nm黄色微脉冲激光治疗ME较MLG更为安全有效,在减轻ME、提高患者视力的同时,保护了视功能。 Objective To compare the clinical curative effects of traditional mac- ular laser grid photocoagulation (MLG)and 577 nm yellow micropulse laser for macular edema (ME). Methods For examination of fundus and optical coherence tomo- graphy (OCT) examination of 97 patients ( 116 eyes) with ME were enrolled in this stud- y. The patients were randomly divided into MLG group (46 cases, 57 eyes) and micro- pulse group (51 cases,59 eyes) ,respectively. MLG group received 561 nm yellow green continuous wavelength laser photocoagulation, and micropulse group underwent 577 nm yellow micropulse laser treatment. Before and after treatment, all patients underwent the examination of fundus, visual acuity, OCT and microperimetry, the corrected visual acuity,central macular thickness (CMT)and macular retinal 10°mean tetinal sensitive (MS) were detected. In 6 months after treatment for curative time points, the changes of corrected visual acuity, CMT and MS before and after treatment were observed,and the differences between corrected visual acuity, CMT and MS of two groups were compared. Results At 5 months after treatment, the corrected visual acuity in MLG group and micropuise group were 0.41 ± 0.20 .0.44 ± 0. 18, respectively, all which were higher than pre-operation, there was statistical difference ( t = 2.703,3. 398 ,all P 〈 0.05 ). Differences in corrected visual acuity before and after treatment of two groups were 0.07 ± 0.03,0.09 ± 0.02, respectively, there was no statistical difference between two groups ( t = 0. 584, P 〉 0.05 ). CMT after treatment in MLG group and micropulse group were ( 328.13 ± 107.65)μm, ( 316.54 ± 73.21 )μm, re- spectively, there were statistical differences between two groups ( t = 2.028,4.086, all P 〈 0.05 ). Differences in CMT before and after treatment of two groups were (24.71 ± 11.09) μm, (53.27 ± 13.57) μm, respectively, there was no statistical differ- ence between two groups ( t = 1. 891 ,P 〉0.05). MS after treatment of MLG group and micropulse group were (4.33 ± 1.72) dB, (6.52 ± 2.56) dB, respectively, MS after treatment in MLG group was lower than before treatment ( t = 3.381,P 〈 0.05 ), and which in micropulse group was increased ( t = 3. 569 ,P 〈 0.05 ). Differences in MS of MLG, group and micropulse group before and after treatment were ( - 0.89 ± 0.26) dB, ( 1.12 ± 0.31 ) dB, respectively, there was statistical difference between two groups( t =4.791 ,P 〈0.05). Conclusion 577 nm yellow micro pulse laser for ME is more effective than MLG, can improve the visual acuity, reduce ME and protect the visual function.
机构地区 唐山市眼科医院
出处 《眼科新进展》 CAS 北大核心 2014年第2期181-183,共3页 Recent Advances in Ophthalmology
关键词 黄斑水肿 传统格栅样激光 微脉冲激光光凝 macular edema traditional grid laser micropulse photocoagulation
  • 相关文献

参考文献17

  • 1李涛,罗清礼,吴海英.人视网膜激光光凝后荧光血管造影和超微结构研究[J].四川大学学报(医学版),2004,35(2):234-237. 被引量:12
  • 2Lewis H, Schachat AP, Haimann MH, Haller JA, Quinlan P, von Fricken MA, et al. Choroidal neovascularization after laser pho- tocoagulation for diabetic macular edema [J]. Ophthalmology, 1990,97(4) :503-510.
  • 3Varley MP,Frank E,Pumell EW. Subretinal neovascularization af- ter focal argon laser for diabetic macular edema [ J ]. Ophthal- mology, 1988,95 ( 5 ) :557-573.
  • 4Wallow IH, Bindley CD. Focal photocoagulation of diabetic mac- ular edema: a clinic pathologic case report [J]. Retina, J 988.8 (4) :261-269.
  • 5Rutledge BK,Wallow IH,Poulsen GL. Sub-pigment epithelial mem- branes after photocoagulation for diabetic macular edema [ J ]. Arch Ophthalmol, 1993,1 11 (5) :508-613.
  • 6Schatz H, Madeira D, McDonald HR, Johnson RN. Progressive enlargement of laser scars following grid laser photocoagulation for diffuse diabetic macular edema[ J]. Arch Ophthalmol, 1991, 109(11 ) :1549-1551.
  • 7Lovestam-Adrian M,Agardh E. Photocoagulation of diabetic mac- ular edema complications and visual outcome [ J ]. Acta Ophthal- tool Scand ,2000 , 78 ( 6 ) :667-671.
  • 8Schuele G, Rumohr M, Huettmann G, Brinkmann R. RPE damage thresholds and mechanisms for laser exposure in the micro-sec- ond to millisecond time regimen[ J]. Invest Ophthalmol Vis Sci, 2005.46(2) :714-719.
  • 9黎晓新.热效应激光治疗的波长选择//黎晓新,廖菊生.眼底病激光治疗指南.北京:人民卫生出版社,2009:89.
  • 10张风,张斯桦.多波长精确治疗:眼底病激光治疗的发展方向[J].中华眼底病杂志,1997,13(4):209-209. 被引量:16

二级参考文献14

  • 1王言纯.激光治疗对不同分期糖尿病视网膜病变患者视功能的改善作用[J].中国临床康复,2005,9(3):32-33. 被引量:4
  • 2罗清礼.增殖性糖尿病视网膜病变全视网膜光凝一例的光镜和电镜观察[J].眼底病,1990,6(3):162-162.
  • 3Fam NP, Verma S.Clinical guide to angiogenesis[J].Circulation,2003,108(21):2613-2618.
  • 4Schoppet M, Chavakis T.Molecular interactions and functional interference between vitronectin and transforming growth factor-beta[J].Lab Invest,2002,82(1):37-46.
  • 5Ortega N, Hutchings H.Signal relays in the VEGF system[J]. Front Biosci,1999,4:D141-D152.
  • 6James C, Daniel M, Stephen B,et al. Proliferative hemangiomas:analysis of cytokine gene expresion and angiogenesis[J]. Plast Reconsr Surg,1999,103(1):1-9.
  • 7Schaper W, Scholz D. Factors regulating arteriogenesis.arteriosclerosis[J].Thromb Vascular Biol,2003,23(7):1143-1151.
  • 8Jang YC, Arumugam S, Fergusion M,et al. Changes in matrix composition during the growth and regresion of human hemangiomas[J]. J Surg Res,1998,80(1): 9-15.
  • 9Bielenberg DR, Bucana CD, Sanchez R,et al. Progressive growth of infantile cutaneous hemangiomas is directly correlated with hyperplasia and angiogenesis of adjacent epidermis and inversely correlated with expression of the endogenous angiogenesis inhibitor,IFN[J].Int J Oncol, 1999, 14(3):401-408.
  • 10Sander B,Larsen M, Engler C,et al. Diabetie macular edema. The effect of photocoagulation on fluorecein transport across the bloodretinalbarrier[ J]. Br J ophthalmol,2002 86 ( 10 ) : 1139-1142.

共引文献49

同被引文献75

  • 1Pedro Romero-Aroca.Managing diabetic macular edema: The leading cause of diabetes blindness[J].World Journal of Diabetes,2011,2(6):98-104. 被引量:16
  • 2杨培增,张震,周红颜,黄祥坤,俞琼,王红,李兵,高杨,朱莲香.葡萄膜炎致盲目特点及原因探讨[J].中华眼底病杂志,2005,21(6):350-352. 被引量:30
  • 3李欣,张小平,褚利群,陈彬彬,侯勤英.氩激光治疗糖尿病性视网膜病变并发症分析[J].中国实用眼科杂志,2007,25(3):342-343. 被引量:10
  • 4Ciardella AP, Klancnik J, Schiff W, et al. Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: an optical coherence tomography study. Br J Ophthalmol 2004;88(9) :1131-1136.
  • 5Li X, Xu G, Wang Y, et al . Safety and efficacy of conbercept in neovascular age-related macular degeneration: results from a 12-month randomized phase 2 study : AURORA study. Ophthalmology 2014 ; 121 (9) :1740-1747.
  • 6Chun MY, Hwang HS, Cho HY, et al . Association of vascular endothelial growth factor polymorphisms with nonproliferative and proliferative diabetic retinopathy. J Clin Endocrinol Metab 2010 ;95 (7) : 3547-3551.
  • 7Funastu H, Yanashita H, Lkeda T, et al. Angiotensin- 11 and vascular endothelial. Am J Ophthalmol 2002 ; 133 ( 2 ) :537-543.
  • 8Bhisitkul RB. Vascular endothelial growth factor biology: clinical implications for ocular treatments. Br J Ophthalmol 2006 ;90(12) :1542-1547.
  • 9Crawford TN, Alfaro DV 3rd, Kerrison JB, et al. Diabetic retinopathy and angiogenesis. Curr Diabetes Rev 2009 ;5( 1 ) :8-13.
  • 10Burak T, Tanyildizi R. The frequency of the nonresponsiveness to intravitreal injection of the anti-vascular endothelial growth factor agent in neovascular age related macular degeneration. Int J Ophthalmic Pathol 2013 ;2(3 ) :2324-2326.

引证文献12

二级引证文献161

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部